Glucocorticoid corticosteroids for Duchenne muscular dystrophy
about
Corticosteroids for the treatment of Duchenne muscular dystrophyCreatine for treating muscle disordersGlucocorticoid corticosteroids for Duchenne muscular dystrophyCreatine for treating muscle disordersThe Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx MiceOnline self-report data for duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefitsAge at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.Gene and cell-mediated therapies for muscular dystrophy.Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.A Dutch guideline for the treatment of scoliosis in neuromuscular disorders.Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.Therapeutics in duchenne muscular dystrophy.Molecular therapeutic strategies targeting Duchenne muscular dystrophyNovel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agentsInhibition of prostaglandin D synthase suppresses muscular necrosis.Gene therapy in large animal models of muscular dystrophy.Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results.Retrospective cohort study comparing the efficacy of prednisolone and deflazacort in children with muscular dystrophy: A 6 years' experience in a South Indian teaching hospital.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Predicting steroid response in muscle disease.RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.
P2860
Q24185788-69177ABF-EDE9-4B8B-AA5B-7C3CBC53F8EEQ24236598-72015EBF-2893-4A26-B692-59FF354FE31CQ24242199-AF228239-C5BF-4595-8C01-32C744A6D564Q24246414-C98725F9-B62E-4F78-9B97-F7F8FC8228EDQ24628875-4E060E43-DA18-4EEF-9986-8DB1DE759DC2Q28544012-24610830-3E01-4D1D-98BE-569AF95CAC9DQ31056857-DABA11E4-E553-43A2-AC43-1959B0634E02Q33831193-3C1B58BB-7A83-4231-9F5C-3F569B3A5E2EQ34124872-6B6AC5A7-4051-4049-BA4E-7457BC683367Q34597668-C88F387F-3239-4596-A929-ECC5A8C5589CQ35575973-23C6B3D1-D021-4FB4-9714-EC2CB62FD447Q36043923-DEB7E549-4B78-4F33-823B-D12BB748D808Q36428758-59829B3F-BD27-42B5-A3D4-91B32C75DF45Q36907560-78F4975C-270D-4102-9BA0-FCF2B30B8D50Q36925191-2FCA48FC-ABF8-448B-A116-7250AA374E20Q37164193-FCA0C748-438A-47F0-BD09-BB8A6CAD3256Q37396408-1177815A-94A9-45CE-A104-B028F6F283E8Q38015418-DF0078BD-47EE-4150-815C-95CB54046F1AQ41052606-52BC33B7-9A95-4BD2-A376-AD2CB12F791AQ42363358-B61C459F-FADE-439E-ADE7-8DE476B8D0B5Q42718466-FFE24DF3-FE18-4517-9AC5-10763E890E99Q50977301-620C5362-FA1C-4405-BFAE-DCD3A4BE63E1
P2860
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@ast
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en-gb
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@nl
type
label
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@ast
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en-gb
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@nl
prefLabel
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@ast
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en-gb
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@nl
P2093
P3181
P1476
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
@en
P2093
P2860
P304
P3181
P356
10.1002/14651858.CD003725.PUB2
P577
2004-01-01T00:00:00Z